Alec W. Gross

1.8k total citations
16 papers, 1.4k citations indexed

About

Alec W. Gross is a scholar working on Oncology, Genetics and Hematology. According to data from OpenAlex, Alec W. Gross has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Genetics and 7 papers in Hematology. Recurrent topics in Alec W. Gross's work include Chronic Lymphocytic Leukemia Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Alec W. Gross is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Alec W. Gross collaborates with scholars based in United States, Germany and Italy. Alec W. Gross's co-authors include Harvey F. Lodish, Jing Zhang, Merav Socolovsky, Ruibao Ren, Moonkyoung Um, Xiaowu Zhang, Joyce Miller, David C. Page, Eric S. Lander and Robert D. Dredge and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Blood.

In The Last Decade

Alec W. Gross

16 papers receiving 1.4k citations

Peers

Countries citing papers authored by Alec W. Gross

Since Specialization

Citations

This map shows the geographic impact of Alec W. Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alec W. Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alec W. Gross more than expected).

Fields of papers citing papers by Alec W. Gross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alec W. Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alec W. Gross. The network helps show where Alec W. Gross may publish in the future.

Co-authorship network of co-authors of Alec W. Gross

This figure shows the co-authorship network connecting the top 25 collaborators of Alec W. Gross. A scholar is included among the top collaborators of Alec W. Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alec W. Gross. Alec W. Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A Generic Approach for Miniaturized Unbiased High-Throughput Screens of Bispecific Antibodies and Biparatopic Antibody–Drug Conjugates 2024 ·International Journal of Molecular Sciences ·(unknown), Stephan Dickgießer, (unknown), (unknown), (unknown), (unknown), (unknown), Ilja Küsters, (unknown), (unknown), Sebastian W. Fuchs, (unknown), Alec W. Gross, (unknown), Simon Krah, Stefan Zielonka, Achim Doerner	6
2	Avelumab internalization by human circulating immune cells is mediated by both Fc gamma receptor and PD-L1 binding 2021 ·OncoImmunology ·Hulin Jin, (unknown), Berend Neuteboom, Sean D. McKenna, (unknown), Alec W. Gross, (unknown), (unknown), (unknown), Lars Toleikis, Markus Fluck, (unknown), Ti Cai	21
3	195 Avelumab internalization and lysosomal degradation by circulating immune cells in human is mediated by both Fc gamma Receptor (FcgR) and PD-L1 binding 2020 ·Regular and Young Investigator Award Abstracts ·Hulin Jin, (unknown), Berend Neuteboom, Sean D. McKenna, (unknown), Alec W. Gross, (unknown), Lars Toleikis, Markus Fluck, (unknown), Ti Cai	2
4	Constant domain-exchanged Fab enables specific light chain pairing in heterodimeric bispecific SEED-antibodies 2019 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·(unknown), Alec W. Gross, Stefan Becker, Björn Hock, Gerhard Stadlmayr, Florian Rüker, Gordana Wozniak‐Knopp	5
5	Anti-EGFR biparatopic-SEED antibody has enhanced combination-activity in a single molecule 2012 ·Archives of Biochemistry and Biophysics ·Christie Kelton, John S. Wesolowski, (unknown), (unknown), David Fischer, Emmi Kurosawa, Sean D. McKenna, Alec W. Gross	16
6	Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies 2011 ·Protein Engineering Design and Selection ·Marco Muda, Alec W. Gross, (unknown), Changjiu He, Emmi Kurosawa, (unknown), (unknown), Mikhail Soloviev, Anne Bernhardt, David Fischer, John S. Wesolowski, Christie Kelton, Berend Neuteboom, B. Hock	44
7	The Membrane-proximal Region of the Thrombopoietin Receptor Confers Its High Surface Expression by JAK2-dependent and -independent Mechanisms 2006 ·Journal of Biological Chemistry ·Wei Tong, Rita Sulahian, Alec W. Gross, (unknown), Harvey F. Lodish, Lily Huang	30
8	A “classical” homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells 2006 ·Cellular Signalling ·Moonkyoung Um, Alec W. Gross, Harvey F. Lodish	122
9	Active Conformation of the Erythropoietin Receptor 2006 ·Journal of Biological Chemistry ·Xiaohui Lü, Alec W. Gross, Harvey F. Lodish	73
10	Cellular Trafficking and Degradation of Erythropoietin and Novel Erythropoiesis Stimulating Protein (NESP) 2005 ·Journal of Biological Chemistry ·Alec W. Gross, Harvey F. Lodish	104
11	c-CBL is not required for leukemia induction by Bcr-Abl in mice 2003 ·Oncogene ·Daniela M. Dinulescu, Lisa J. Wood, Lei Shen, Marc Loriaux, Christopher L. Corless, Alec W. Gross, Ruibao Ren, Michael W. Deininger, Brian Druker	12
12	Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry–based novel culture system 2003 ·Blood ·Jing Zhang, Merav Socolovsky, Alec W. Gross, Harvey F. Lodish	327
13	The NH ₂ -Terminal Coiled-Coil Domain and Tyrosine 177 Play Important Roles in Induction of a Myeloproliferative Disease in Mice by Bcr-Abl 2001 ·Molecular and Cellular Biology ·Xiaowu Zhang, Ramesh Subrahmanyam, (unknown), Alec W. Gross, Ruibao Ren	94
14	Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells 2000 ·Oncogene ·Alec W. Gross, Ruibao Ren	14
15	Bcr-Abl with an SH3 Deletion Retains the Ability To Induce a Myeloproliferative Disease in Mice, yet c-Abl Activated by an SH3 Deletion Induces Only Lymphoid Malignancy 1999 ·Molecular and Cellular Biology ·Alec W. Gross, Xiaowu Zhang, Ruibao Ren	53
16	A genetic map of the mouse with 4,006 simple sequence length polymorphisms 1994 ·Nature Genetics ·William F. Dietrich, Joyce Miller, Robert Steen, Mark Merchant, (unknown), (unknown), Alec W. Gross, (unknown), Michael Wessel, Robert D. Dredge, (unknown), Lincoln Stein, Nathan Goodman, David C. Page, Eric S. Lander	485

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact